Protective effect of metalloporphyrins against Cisplatin-induced kidney injury in mice

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pan, Hao ^a   Shen, Kezhen ^b   Wang, Xueping ^a   Meng, Hongzhou ^a   Wang, Chaojun ^a   Jin, Baiye ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CREATININE; HEME OXYGENASE 1; IRON TETRAKIS (1 METHYL 4 PYRIDYL)PORPHYRIN PENTACHLORIDEPORPHYRIN; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN; METALLOPORPHYRIN; NITROGEN; PEROXYNITRITE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA FRAGMENTATION; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; MOUSE; NEPHROTOXICITY; NICK END LABELING; NITRATION; NITRATIVE STRESS; NONHUMAN; PROTEIN FUNCTION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CASPASE 3; CISPLATIN; CYTOPROTECTION; DNA FRAGMENTATION; HEME OXYGENASE-1; KIDNEY TUBULES; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; NITRATES; OXIDATIVE STRESS;

EID: 84898017304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086057     Document Type: Article

References (65)

1. Fram RJ (1992) Cisplatin and platinum analogues: recent advances. Curr Opin Oncol 4: 1073-1079.
2. Dillioglugil MO, Maral Kir H, Gulkac MD, Ozon Kanli A, Ozdogan HK, et al. (2005) Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol Int 75: 340-344. (Pubitemid 41752584)
3. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, et al. (1996) Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 9: 139-142. (Pubitemid 26144593)
4. Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12: 2683-2690. (Pubitemid 33115415)
5. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, et al. (2004) The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 23: 29-34. (Pubitemid 38263155)
6. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-1437.
7. Szabo C, Day BJ, Salzman AL (1996) Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 381: 82-86.
8. Estevez AG, Spear N, Manuel SM, Radi R, Henderson CE, et al. (1998) Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 18: 923-931. (Pubitemid 28112915)
9. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, et al. (1999) Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 127: 685-692. (Pubitemid 29276654)
10. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, et al. (2000) Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726-736. (Pubitemid 30351074)
11. Aleksunes LM, Goedken MJ, Rockwell CE, Thomale J, Manautou JE, et al. (2010) Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J Pharmacol Exp Ther 335: 2-12.
12. Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, et al. (2010) Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 87: 240-245.
13. Sahin K, Tuzcu M, Sahin N, Ali S, Kucuk O (2010) Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 48: 2670-2674.
14. Choi BM, Lim DW, Lee JA, Gao SS, Kwon DY, et al. (2008) Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food 11: 230-236. (Pubitemid 351948178)
15. Domitrovic R, Cvijanovic O, Pernjak-Pugel E, Skoda M, Mikelic L, et al. (2013) Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol 62C: 397-406.
16. Mukhopadhyay P, Pan H, Rajesh M, Batkai S, Patel V, et al. (2010) CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br J Pharmacol 160: 657-668.
17. Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, et al. (2010) Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 48: 457-467.
18. Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, et al. (2009) Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 328: 708-714.
19. Guerrero-Beltran CE, Mukhopadhyay P, Horvath B, Rajesh M, Tapia E, et al. (2012) Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. J Nutr Biochem 23: 494-500.
20. Chirino YI, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Pedraza-Chaverri J (2008) Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245: 18-23.
21. Chirino YI, Hernandez-Pando R, Pedraza-Chaverri J (2004) Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 4: 20.
22. Mukhopadhyay P, Horvath B, Zsengeller Z, Zielonka J, Tanchian G, et al. (2012) Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 52: 497-506.
23. Mukhopadhyay P, Horvath B, Kechrid M, Tanchian G, Rajesh M, et al. (2011) Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radic Biol Med 51: 1774-1788.
24. Li PK, Burdmann EA, Mehta RL (2013) Acute kidney injury: Acute kidney injury-global health alert. Nat Rev Nephrol 9: 133-135.
25. Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4: 889-901. (Pubitemid 36722480)
26. Boogaard PJ, Mulder GJ, Nagelkerke JF (1990) Cisplatin nephrotoxicity and platinum-metallothioneins: uptake and toxicity in proximal tubular cells from rat kidney. Contrib Nephrol 83: 208-212.
27. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23: 460-464. (Pubitemid 37176691)
28. Brozovic A, Ambriovic-Ristov A, Osmak M (2010) The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol 40: 347-359.
29. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424. (Pubitemid 46217686)
30. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A (2001) Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30: 463-488. (Pubitemid 32162954)
31. Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, et al. (2006) Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 41: 886-895. (Pubitemid 44262482)
32. Zingarelli B, Day BJ, Crapo JD, Salzman AL, Szabo C (1997) The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 120: 259-267. (Pubitemid 27039275)
33. Liu D, Bao F, Prough DS, Dewitt DS (2005) Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J Neurotrauma 22: 1123-1133. (Pubitemid 41532549)
34. Batinic-Haberle I, Cuzzocrea S, Reboucas JS, Ferrer-Sueta G, Mazzon E, et al. (2009) Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Free Radic Biol Med 46: 192-201.
35. Loukili N, Rosenblatt-Velin N, Li J, Clerc S, Pacher P, et al. (2011) Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res 89: 586-594.
36. Saba H, Batinic-Haberle I, Munusamy S, Mitchell T, Lichti C, et al. (2007) Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic Biol Med 42: 1571-1578. (Pubitemid 46591998)
37. Kang JL, Lee HS, Pack IS, Leonard S, Castranova V (2001) Iron tetrakis (n-methyl-4′-pyridyl) porphyrinato (FeTMPyP) is a potent scavenging antioxidant and an inhibitor of stimulant-induced NF-kappaB activation of raw 264.7 macrophages. J Toxicol Environ Health A 64: 291-310. (Pubitemid 32989444)
38. Nangle MR, Cotter MA, Cameron NE (2004) Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol 502: 143-148. (Pubitemid 39311375)
39. Dhar A, Kaundal RK, Sharma SS (2006) Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacol Res 54: 311-316. (Pubitemid 44269349)
40. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53: 394-401. (Pubitemid 28097855)
41. Zielonka J, Sikora A, Joseph J, Kalyanaraman B (2010) Peroxynitrite is the major species formed from different flux ratios of co-generated nitric oxide and superoxide: direct reaction with boronate-based fluorescent probe. J Biol Chem 285: 14210-14216.
42. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620-1624.
43. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487.
44. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250. (Pubitemid 21909347)
45. Crow JP, Beckman JS (1995) The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol 196: 57-73.
46. Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, et al. (2000) Cytochrome c nitration by peroxynitrite. J Biol Chem 275: 21409-21415. (Pubitemid 30481842)
47. Hortelano S, Alvarez AM, Bosca L (1999) Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages. FASEB J 13: 2311-2317.
48. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, et al. (2001) Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci U S A 98: 12056-12061. (Pubitemid 32959825)
49. Yamakura F, Taka H, Fujimura T, Murayama K (1998) Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 273: 14085-14089. (Pubitemid 28319114)
50. Trujillo M, Radi R (2002) Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. Arch Biochem Biophys 397: 91-98. (Pubitemid 34848253)
51. Gozzelino R, Jeney V, Soares MP (2010) Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354.
52. Keyse SM, Tyrrell RM (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86: 99-103. (Pubitemid 19036341)
53. Applegate LA, Luscher P, Tyrrell RM (1991) Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 51: 974-978.
54. Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650.
55. Domitrovic R, Cvijanovic O, Pugel EP, Zagorac GB, Mahmutefendic H, et al. (2013) Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney. Toxicology.
56. Kim MG, Yang HN, Kim HW, Jo SK, Cho WY, et al. (2010) IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity. J Korean Med Sci 25: 557-563.
57. Ozkaya O, Yavuz O, Can B, Dilek M, Savli E, et al. (2010) Effect of rosiglitazone on cisplatin-induced nephrotoxicity. Ren Fail 32: 368-371.
58. Lee S, Kim W, Moon SO, Sung MJ, Kim DH, et al. (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 21: 2096-2105. (Pubitemid 44295034)
59. Kumar P, Prashanth KS, Gaikwad AB, Vij M, Barua CC, et al. (2013) Disparity in actions of rosiglitazone against cisplatin-induced nephrotoxicity in female Sprague-Dawley rats. Environ Toxicol Pharmacol 36: 883-890.
60. Broeders N, Abramowicz D (2002) Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int 61: 354-355. (Pubitemid 34075167)
61. Mukhopadhyay P, Rajesh M, Batkai S, Kashiwaya Y, Hasko G, et al. (2009) Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 296: H1466-1483.
62. Liaudet L, Rosenblatt-Velin N, Pacher P (2013) Role of peroxynitrite in the cardiovascular dysfunction of septic shock. Curr Vasc Pharmacol 11: 196-207.
63. Pacher P, Szabo C (2006) Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 6: 136-141. (Pubitemid 43362126)
64. Pacher P, Schulz R, Liaudet L, Szabo C (2005) Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 26: 302-310. (Pubitemid 40733523)
65. Pacher P, Obrosova IG, Mabley JG, Szabo C (2005) Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12: 267-275. (Pubitemid 40305619)